| Stage | BOBS | % of rev | SGRY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $620M | 100.00% | $849M | 100.00% | SGRY ×1.37 |
| Gross profit | $319M | 51.50% | $596M | 70.18% | SGRY +18.7pp |
| Operating income | $78M | 12.67% | $102M | 12.03% | BOBS +0.6pp |
| Pre-tax income | $80M | 12.84% | $32M | 3.80% | BOBS +9.0pp |
| Net income | $58M | 9.33% | $30M | 3.50% | BOBS +5.8pp |
| Stage | BOBS | SGRY | Gap · A − B |
|---|---|---|---|
| Revenue | $620M100.00% | $849M100.00% | SGRY ×1.37 |
| Gross profit | 51.50%$319M | 70.18%$596M | SGRY +18.7pp |
| Operating income | 12.67%$78M | 12.03%$102M | BOBS +0.6pp |
| Pre-tax income | 12.84%$80M | 3.80%$32M | BOBS +9.0pp |
| Net income |
| 9.33%$58M |
| 3.50%$30M |
| BOBS +5.8pp |
No shared counterparties.